Case report reveals high aggressiveness of esophageal carcinoma with neuroendocrine features, suggesting need for improved diagnostic criteria.
This study reports a case of a 74-year-old male patient with esophageal carcinoma who presented two months before admission with dysphagia and chest pain during meals. Preoperative imaging and biopsy revealed a mixed esophageal neuroendocrine carcinoma and non-neuroendocrine carcinoma (squamous cell carcinoma, SCC), with small-cell neuroendocrine carcinoma (SCNEC) comprising the predominant component (65%). Based on the preferences of the patient and his family, surgical treatment was performed first. Postoperative pathological examination revealed poorly differentiated SCC as the predominant component (approximately 90%), with SCNEC accounting for about 10% and lymph node metastasis present, indicating that the NEC component exhibited marked aggressiveness. This case highlights the importance of multiple deep preoperative biopsies and calls for a reevaluation of the WHO definition of Mixed Neuroendocrine-Non-Neuroendocrine Neoplasm (MiNEN), particularly the 30% threshold. Further clinical studies are warranted to refine the diagnostic criteria and therapeutic strategies for MiNEN to improve patient outcomes.
No takes yet. Share an insight, caveat, or question.
Ding et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: